Accounts Receivable (Quarterly) Chart

View Accounts Receivable (Quarterly) for EPC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Receivable (Quarterly) Chart
Start Trial

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 119.40M
March 31, 2026 185.40M
December 31, 2025 154.00M
September 30, 2025 137.80M
June 30, 2025 153.20M
March 31, 2025 178.20M
December 31, 2024 120.50M
September 30, 2024 109.40M
June 30, 2024 155.00M
March 31, 2024 130.60M
December 31, 2023 112.50M
September 30, 2023 106.20M
June 30, 2023 121.50M
March 31, 2023 160.80M
December 31, 2022 123.10M
September 30, 2022 136.90M
June 30, 2022 155.20M
March 31, 2022 183.80M
December 31, 2021 154.40M
September 30, 2021 150.70M
June 30, 2021 149.60M
March 31, 2021 195.10M
December 31, 2020 167.00M
September 30, 2020 158.80M
June 30, 2020 178.20M
Date Value
March 31, 2020 209.80M
December 31, 2019 183.20M
September 30, 2019 205.60M
June 30, 2019 241.60M
March 31, 2019 250.80M
December 31, 2018 163.60M
September 30, 2018 226.50M
June 30, 2018 225.60M
March 31, 2018 258.30M
December 31, 2017 183.10M
September 30, 2017 224.10M
June 30, 2017 312.90M
March 31, 2017 311.00M
December 31, 2016 228.40M
September 30, 2016 260.70M
June 30, 2016 308.70M
March 31, 2016 291.50M
December 31, 2015 240.00M
September 30, 2015 279.80M
June 30, 2015 507.10M
March 31, 2015 448.90M
December 31, 2014 456.00M
September 30, 2014 495.00M
June 30, 2014 508.20M
March 31, 2014 457.70M

Accounts Receivable Definition

Represents change in working capital due to increase or decrease in receivables for the given period.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

View Accounts Receivable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Receivable (Quarterly) Benchmarks

View Accounts Receivable (Quarterly) Benchmarks
Start Trial
Coty, Inc. 525.80M
The Estée Lauder Companies, Inc. 1.518B
Interparfums, Inc. 301.83M
United-Guardian, Inc. 1.691M
BioForce Nanosciences Holdings, Inc. --